|
顯示項目 696231-696255 / 2348674 (共93947頁)
<< < 27845 27846 27847 27848 27849 27850 27851 27852 27853 27854 > >>
每頁顯示[10|25|50]項目
| 嘉南藥理大學 |
2009 |
Prostaglandins
|
Elsevier SDOL |
| 嘉南藥理大學 |
2009 |
Prostaglandins and Other Lipid Mediators
|
Elsevier SDOL |
| 嘉南藥理大學 |
2009 |
Prostaglandins, Leukotrienes and Essential Fatty Acids
|
Elsevier SDOL |
| 臺大學術典藏 |
2019-11-18T02:33:27Z |
Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension
|
WEN-JENG HSUEH;GERARD JENNHWA CHANG;Hsu, Hsao-Hsun;Lai, Ying-Ju;Huang, Chung-Chi;Pang, Jong-Hwei S;Chen, Wei-Jan;Hsu, Pei-Chen;Chen, I-Chen;Li, Hsin-Hsien; Li, Hsin-Hsien; Hsu, Hsao-Hsun; GERARD JENNHWA CHANG; Chen, I-Chen; WEN-JENG HSUEH; Hsu, Pei-Chen; Chen, Wei-Jan; Pang, Jong-Hwei S; Huang, Chung-Chi; Lai, Ying-Ju |
| 臺大學術典藏 |
2021-05-24T03:41:44Z |
Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension
|
Li H.-H.; HSAO-HSUN HSU; Chang G.-J.; Chen I.-C.; Ho W.-J.; Hsu P.-C.; Chen W.-J.; Pang J.-H.S.; Huang C.-C.; Lai Y.-J. |
| 國立臺灣大學 |
2004 |
Prostanoid FP, IP與TP受體在牙髓細胞活化之訊息傳導機制(I)
|
鄭景暉 |
| 國立臺灣大學 |
1994 |
Prostanoids Oppose Rapid Baroreceptor Resetting in Rabbits
|
陳幸一; Chapleau, M.; McDowell, T. S.; Chen, Hsing I.; Chapleau, M.; McDowell, T. S. |
| 國立交通大學 |
2019-08-02T02:15:28Z |
Prostasin Impairs Epithelial Growth Factor Receptor Activation to Suppress Dengue Virus Propagation
|
Lin, Chun-Kuang; Tseng, Chin-Kai; Wu, Yu-Hsuan; Lin, Chun-Yu; Huang, Chung-Hao; Wang, Weng-Hung; Liaw, Chih-Chuang; Chen, Yen-Hsu; Lee, Jin-Ching |
| 國立成功大學 |
2019 |
Prostasin Impairs Epithelial Growth Factor Receptor Activation to Suppress Dengue Virus Propagation
|
Lin, C.-K.;Tseng, C.-K.;Wu, Y.-H.;Lin, C.-Y.;Huang, C.-H.;Wang, Wang W.-H.;Liaw, C.-C.;Chen, Y.-H.;Lee, J.-C. |
| 臺大學術典藏 |
2021-01-26T02:27:45Z |
Prostate calcification worsen lower urinary tract symptoms in middle-aged men
|
Yang H.-J.; Huang K.-H.; Wang C.-W.; HONG-CHIANG CHANG; Yang T.-K. |
| 臺大學術典藏 |
2021-01-28T02:03:30Z |
Prostate calcification worsen lower urinary tract symptoms in middle-aged men
|
Yang H.-J.;Kuo-How Huang;Wang C.-W.;Chang H.-C.;Yang T.-K.; Yang H.-J.; KUO-HOW HUANG; Wang C.-W.; Chang H.-C.; Yang T.-K. |
| 亞洲大學 |
2022-09-01 |
Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
|
Ying-Chieh, Chieh C;Chang, Ying-Chieh;Chen, Szu-Ju;Chen, Szu-Ju;Hu, Wei-Hsuan;Huang, Wei-Hsuan;Hua, Chi-Ping;Huang, Chi-Ping;陳永祥;Chen, Yung-Hsian;Chen, Wen-Chi;Chen, Wen-Chi |
| 亞洲大學 |
2022-09-01 |
Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case Report
|
Ying-Chieh, Chieh C;Chang, Ying-Chieh;Chen, Szu-Ju;Chen, Szu-Ju;Hu, Wei-Hsuan;Huang, Wei-Hsuan;Hua, Chi-Ping;Huang, Chi-Ping;陳永祥;Chen, Yung-Hsian;Chen, Wen-Chi;Chen, Wen-Chi |
| 國家衛生研究院 |
2025-01-16 |
Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition
|
Lin, TP;Chen, PC;Lin, CY;Wang, BJ;Kuo, YY;Yeh, CC;Tseng, JC;Huo, CH;Kao, CL;Shih, LJ;Chen, JK;Li, CY;Hour, TC;Chuu, CP |
| 臺大學術典藏 |
2021-02-02T00:45:59Z |
Prostate cancer in Asia: design of a patient registry to inform real-world treatments, outcomes, and quality of life
|
Liu Y.;Uemura H.;Ye D.;Lee J.Y.;Chiong E.;Yeong-Shiau Pu;Razack A.H.A.;Pripatnanont C.;Rawal S.;Low G.K.M.;Qiu H.;Chow W.H.;Van Kooten Losio M.; Liu Y.; Uemura H.; Ye D.; Lee J.Y.; Chiong E.; YEONG-SHIAU PU; Razack A.H.A.; Pripatnanont C.; Rawal S.; Low G.K.M.; Qiu H.; Chow W.H.; Van Kooten Losio M. |
| 國立臺灣大學 |
1999 |
Prostate Cancer in Taiwan
|
蒲永孝; PU, YEONG-SHIAU |
| 臺大學術典藏 |
2021-05-27T03:14:53Z |
Prostate Cancer in Taiwan
|
YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-05-27T05:17:05Z |
Prostate Cancer in Taiwan
|
YEONG-SHIAU PU |
| 臺大學術典藏 |
2021-02-02T00:47:08Z |
Prostate cancer in Taiwan: Epidemiology and risk factors
|
Yeong-Shiau Pu; YEONG-SHIAU PU |
| 嘉南藥理大學 |
2020 |
Prostate cancer is one of the most common cancers and the second leading cause of death in men. The incidence of prostate cancer is also growing rapidly worldwide today. Therefore, the search for new and more effective treatments is urgently needed. First of all, we used 5 different cell lines to screen 27 compounds, the results showed that No.7 compound can be specifically induced the death in LNCaP and PC-3 cell prostate cancer cells. Furthermore, No.7 compound can significantly inhibit the c
|
黃怡甄 |
| 國立交通大學 |
2014-12-08T15:28:24Z |
Prostate Cancer Marker Sensing Under Nanostructural Biochip Technique
|
Wu, Chungshu; Ko, Fuhsiang; Wu, Chichang; Pan, Tungming; Chuang, Chengkeng; Pang, Seetong |
| 國立臺灣大學 |
2011 |
Prostate Cancer Mortality in Taiwanese Men: Increasing Age-Standardized Trend in General Population and Increased Risk in Diabetic Men
|
曾慶孝; TSENG, CHIN-HSIAO |
| 臺大學術典藏 |
2020-06-01T08:33:46Z |
Prostate cancer mortality in Taiwanese men: Increasing age-standardized trend in general population and increased risk in diabetic men
|
Chin-Hsiao Tseng; CHIN-HSIAO TSENG |
| 中山醫學大學 |
2017-01 |
Prostate cancer mortality-to-incidence ratios are associated with cancer care disparities in 35 countries
|
Chen, S.-L.; Wang, S.-C.; Ho, C.-J.; Kao, Y.-L.; Hsieh, T.-Y.; Chen, W.-J.; Chen, C.-J.; Wu, P.-R.; Ko, J.-L.; Lee, H.; Sung, W.-W. |
| 國立成功大學 |
2020 |
Prostate cancer risk calculator apps in a Taiwanese population cohort: Validation study
|
Chen, I.-H.A.;Chu, Chu C.-H.;Lin, J.-T.;Tsai, J.-Y.;Yu, C.-C.;Sridhar, A.N.;Sooriakumaran, P.;Loureiro, R.C.V.;Chand, M. |
顯示項目 696231-696255 / 2348674 (共93947頁)
<< < 27845 27846 27847 27848 27849 27850 27851 27852 27853 27854 > >>
每頁顯示[10|25|50]項目
|
